COVID-19 vaccination in Bosnia and Herzegovina
Date | 12 February 2021 – present |
---|---|
Location | Bosnia and Herzegovina |
Cause | COVID-19 pandemic |
Target | Full immunisation of adults in Bosnia and Herzegovina against COVID-19 |
Participants | 943,394 have received one vaccine dose 846,080 have received two vaccine doses 135,476 have received three vaccine doses |
Outcome | 28.9% of the total Bosnia and Herzegovina population have received one vaccine dose 25.9% of the total Bosnia and Herzegovina population have received two vaccine doses 4.2% of the total Bosnia and Herzegovina population have received three vaccine doses |
The COVID-19 vaccination campaign in Bosnia and Herzegovina is a mass immunization campaign that was put in place by the Bosnian authorities in order to respond to the ongoing COVID-19 pandemic. It started on 12 February 2021.[1]
As of 29 January 2022, 943,394 people have received the first dose, 846,080 people have received the second dose and 135,476 people have received the third dose.[2]
Vaccines on order
There are five types of COVID-19 vaccines currently being used in Bosnia and Herzegovina. As of 25 January 2022, 3,948,830 vaccines doses have arrived to the country.[3]
Vaccine | Doses arrived | Approval | Deployment |
---|---|---|---|
Sinopharm BIBP | 1.09 million | Yes | Yes |
Oxford-AstraZeneca | 1.05 million | Yes | Yes |
Pfizer–BioNTech | 284,310 | Yes | Yes |
Sputnik V | 199,300 | Yes | Yes |
CoronaVac | 90,000 | Yes | Yes |
See also
References
- ↑ B.R. (12 February 2021). "Počela vakcinacija u BiH: Rusku vakcinu protiv korone prvi dobio direktor UKC-a RS" (in Bosnian). Klix.ba. Retrieved 12 February 2021.
- ↑ A.S. (25 January 2022). "U BiH stiglo više od 3.900.000 vakcina, potpuno vakcinisano nije ni 900.000 građana, propalo oko 750.000 doza" (in Bosnian). faktor.ba. Retrieved 25 January 2022.
- ↑ A.S. (25 January 2022). "U BiH stiglo više od 3.900.000 vakcina, potpuno vakcinisano nije ni 900.000 građana, propalo oko 750.000 doza" (in Bosnian). faktor.ba. Retrieved 25 January 2022.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.